Multiple Sclerosis Relapsing-remitting
📧 Sign up to get email alerts when something new happens for Multiple Sclerosis Relapsing-remitting.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-28Clinical Trial Results: Cladribine Tablets: Collaborative Study to Evaluate Impact On Central Nervous System Biomarkers in Multiple Sclerosis [Phase 4]
Phase 4 clinical trial evaluating the impact of cladribine tablets on central nervous system biomarkers in multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2026-07-20Clinical Trial Results: Effects of Chiropractic Care on Cytokine Levels in Multiple Sclerosis [NA]
Clinical trial results evaluating the effects of chiropractic care on cytokine levels in relapsing-remitting multiple sclerosis.
-
CLINICAL_TRIALS trial_result · 2025-03-25Clinical Trial Update: A Canadian Study of Persistence on Ofatumumab Using Patient Support Program Data
A Canadian observational study examining patient persistence with Ofatumumab in relapsing-remitting multiple sclerosis using patient support…
-
CLINICAL_TRIALS trial_result · 2024-03-08Clinical Trial Update: IMCY-0141 Safety and Efficacy in Multiple Sclerosis - ISEMIS Study [Phase 1, Phase 2]
Clinical trial update for IMCY-0141 in multiple sclerosis (relapsing-remitting) spanning Phase 1 and Phase 2 with safety and efficacy endpoi…
-
CLINICAL_TRIALS trial_result · 2024-03-07Clinical Trial Update: Study on the Effectiveness of EGb 761® vs Placebo Used for Cognitive Impairment in Patients With Multiple Sclerosis [Phase 3]
Phase 3 trial assessing EGb 761® versus placebo for cognitive impairment in adults with relapsing-remitting multiple sclerosis; study comple…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-05-16Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Dimethyl Fumarate (Tecfidera) and Peginterferon Beta-1a (Plegridy) for the Treatment of Relapsing-Remitting Multiple Sclerosis in Pediatric Participants [Phase 3]
Phase 3 pediatric trial evaluating Dimethyl Fumarate and Peginterferon Beta-1a for relapsing-remitting multiple sclerosis was terminated.
-
CLINICAL_TRIALS trial_result · 2022-04-28Clinical Trial Update: B Cell Tailored Ocrelizumab Versus Standard Ocrelizumab in Relapsing Remitting Multiple Sclerosis [Phase 4]
Phase 4 trial comparing B cell-tailored ocrelizumab to standard ocrelizumab in relapsing-remitting multiple sclerosis; current status is unk…
-
CLINICAL_TRIALS trial_result · 2021-10-12Clinical Trial Update: RItuximab Versus FUmarate in Newly Diagnosed Multiple Sclerosis. [Phase 3]
Phase 3 trial comparing Rituximab versus Fumarate in newly diagnosed relapsing-remitting multiple sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2021-09-08Clinical Trial Update: Comparative Clinical Trial to Evaluate Efficacy, Safety and Tolerance of BCD-054 and Avonex® for Treatment of Patients With Remitting-relapsing Multiple Sclerosis [Phase 2, Phase 3]
Phase 2/3 trial comparing BCD-054 with Avonex for relapsing-remitting multiple sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2021-07-22Clinical Trial Update: A Pilot Study to Characterize the Biological Effect of a Pre-planned 12 Week Dose Interruption of Natalizumab [Phase 4]
A Phase 4 pilot study evaluating the biological effects of a planned 12-week interruption of natalizumab in patients with relapsing forms of…
-
CLINICAL_TRIALS trial_result · 2021-06-03Clinical Trial Update: Acthar Gel for Multiple Sclerosis That Keeps Getting Better and Worse (RRMS) [Phase 4]
Phase 4 trial update for Acthar Gel in relapsing-remitting multiple sclerosis; study terminated with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-04-19Clinical Trial Update: RItuximab Long-Term DOSE Trial in Multiple Sclerosis - RIDOSE-MS [Phase 3]
Phase 3 clinical trial update for rituximab long-term dose in relapsing-remitting multiple sclerosis (RIDOSE-MS).
-
CLINICAL_TRIALS trial_result · 2021-01-11Clinical Trial Update: Maximizing Outcome of Multiple Sclerosis Transplantation [Phase 3]
Phase 3 trial update for a transplantation strategy in relapsing-remitting multiple sclerosis; trial terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2020-10-20Clinical Trial Update: Clinical Trial Assessing the HERV-W Env Antagonist GNbAC1 for Efficacy in MS [Phase 2]
Phase 2 clinical trial assessing the HERV-W Env antagonist GNbAC1 for efficacy in relapsing-remitting multiple sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2020-05-26Clinical Trial Update: A Study of Ocrelizumab in Participants With Relapsing Remitting Multiple Sclerosis (RRMS) Who Have Had a Suboptimal Response to an Adequate Course of Disease-Modifying Treatment (DMT) [Phase 3]
Phase 3 trial updating ocrelizumab in relapsing-remitting MS patients with suboptimal response to prior DMT has completed and results posted…
-
CLINICAL_TRIALS trial_result · 2020-05-13Clinical Trial Update: Light Therapy as Treatment for Fatigue in Multiple Sclerosis [NA]
A completed clinical trial investigating light therapy as a treatment for fatigue in relapsing-remitting multiple sclerosis with results pos…
-
CLINICAL_TRIALS trial_result · 2020-02-10Clinical Trial Update: A Pilot Study in Participants With Relapsing Remitting Multiple Sclerosis (RR-MS) [Phase 2]
A Phase 2 pilot trial in relapsing-remitting multiple sclerosis has been terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2019-10-08Clinical Trial Update: Pilot Trial of Domperidone in Relapsing-Remitting Multiple Sclerosis (RRMS) [Phase 2]
A Phase 2 pilot trial evaluating domperidone in relapsing-remitting multiple sclerosis has completed.
-
CLINICAL_TRIALS trial_result · 2019-08-13Clinical Trial Update: ACTH for Fatigue in Multiple Sclerosis Patients [Phase 3]
Phase 3 clinical trial evaluating ACTH for fatigue in patients with Relapsing-Remitting Multiple Sclerosis has completed with results posted…
-
CLINICAL_TRIALS trial_result · 2019-03-20Clinical Trial Update: Impact of Vitamin D Supplementation in Patients With Multiple Sclerosis [Phase 4]
A Phase 4 clinical trial assessing the impact of vitamin D supplementation in patients with relapsing-remitting multiple sclerosis and vitam…
-
CLINICAL_TRIALS trial_result · 2019-01-09Clinical Trial Update: Monitoring of Patients Followed for a Multiple Sclerosis and Treated by Dimethyl-fumarate [Phase 4]
Phase 4 clinical trial update monitoring patients with relapsing-remitting multiple sclerosis treated with dimethyl fumarate.
-
CLINICAL_TRIALS trial_result · 2018-10-11Clinical Trial Update: Investigation of the Effect of Dimethyl Fumarate on T Cells in Patients With Relapsing Remitting Multiple Sclerosis [Phase 4]
Phase 4 trial investigating the effect of dimethyl fumarate on T cells in patients with relapsing-remitting multiple sclerosis has completed…
-
CLINICAL_TRIALS trial_result · 2018-09-20Clinical Trial Update: A Study of Rebif® in Subjects With Relapsing Multiple Sclerosis [Phase 4]
Phase 4 trial update for Rebif in relapsing multiple sclerosis; study completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2017-07-07Clinical Trial Update: Healthy Volunteer Study Using 3 Different Formulations of Firategrast [Phase 1]
Phase 1 healthy volunteer study evaluating three formulations of Firategrast; the study has completed.
-
CLINICAL_TRIALS trial_result · 2016-07-29Clinical Trial Update: Cognitive Disability and Quality of Life of Patients Suffering From Multiple Sclerosis and Treatment With Immunosuppressant [NA]
The completed clinical trial focuses on cognitive disability and quality of life in relapsing-remitting multiple sclerosis patients treated …